Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like iCardiac Technologies Unveils An Innovative And Highly-Customizable eCOA Platform February 21, 2017 Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics September 17, 2017 Nordson, Pounce, Buy Pieces of Vention Medical February 20, 2017
Bay Area's Ultragenyx Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics September 17, 2017